Topcon
7732
TEMONA
3985
Forside
2330
Okamoto Glass
7746
Delta-Fly Pharma
4598
(Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | -0.58%2.36B | -73.18%10.05B | -12.66%2.58B | -78.80%2.82B | -80.44%2.28B | -75.18%2.37B | 0.65%37.45B | -72.92%2.95B | 24.55%13.3B | 38.66%11.64B |
Cost of revenue | 1.73%1.7B | -40.55%7.08B | -10.39%1.83B | -45.34%2B | -54.72%1.59B | -38.44%1.67B | 9.60%11.91B | -36.18%2.04B | -1.27%3.66B | 51.37%3.5B |
Gross profit | -6.07%658.38M | -88.39%2.96B | -17.71%752.22M | -91.51%818.09M | -91.49%692.54M | -89.75%700.95M | -3.04%25.54B | -88.14%914.11M | 38.29%9.64B | 33.84%8.14B |
Operating expense | 16.87%789.11M | -90.27%2.65B | -12.33%657.89M | -93.34%671.07M | -92.87%646.85M | -90.82%675.19M | 9.10%27.25B | -89.54%750.43M | 41.22%10.07B | 64.43%9.07B |
Operating profit | -607.46%-130.74M | 118.28%312.8M | -42.37%94.32M | 134.23%147.02M | 104.90%45.69M | 105.02%25.76M | -225.77%-1.71B | -69.09%163.68M | -169.48%-429.55M | -264.99%-932.27M |
Net non-operating interest income (expenses) | 835.75%71.36M | -70.72%124.17M | -32.74%80.3M | -84.93%29.97M | -93.19%6.28M | -43.41%7.63M | 311.76%424.01M | 466.97%119.39M | 760.76%198.89M | 320.93%92.26M |
Non-operating interest income | 773.18%74.98M | -69.52%133.86M | -28.22%86.99M | -84.58%31.14M | -92.64%7.14M | -54.83%8.59M | 251.01%439.22M | 399.81%121.19M | 620.16%201.97M | 254.33%97.05M |
Non-operating interest expense | 276.69%3.62M | -36.31%9.69M | 270.39%6.69M | -62.03%1.17M | -81.99%862K | -82.63%961K | -31.35%15.21M | -43.37%1.81M | -37.62%3.08M | -12.50%4.79M |
Net investment income | -0.13%-13.85M | -101.02%-29.67M | 95.62%-7.65M | 100.36%7.62M | -100.93%-15.81M | -100.40%-13.83M | -15.73%2.9B | -109.08%-174.49M | -336.92%-2.12B | 176.12%1.71B |
Gain(Loss) on financial instruments designated as cash flow hedges | 0 | 0 | 0 | 155.95%12.11B | 0 | 3.13B | 4.28B | |||
Gain(Loss) on derecognition of available-for-sale financial assets | 0 | -142.28M | -56.79M | 0 | ||||||
Income from associates and other participating interests | 0 | -1,054.63%-4.5B | 0 | 0 | -1.71B | -2.79B | 471.22M | 471.22M | 0 | 0 |
Special income (charges) | 2,355.46%11.69M | 93.00%-5.04M | -99.33%463K | 95.35%-3.64M | 96.22%-2.34M | 139.34%476K | -1,496.26%-71.99M | 84.63%69.48M | -927.51%-78.29M | -285.43%-61.97M |
Less:Other special charges | -2,355.46%-11.69M | 186.26%5.04M | 98.87%-463K | -54.87%3.64M | -92.99%2.34M | -139.34%-476K | 134.15%1.76M | -1,148.08%-40.92M | 230.73%8.06M | 2,650.15%33.41M |
Less:Write off | ---- | --0 | --0 | --0 | ---- | ---- | --70.23M | 31.23%-28.57M | 2,231.41%70.23M | ---- |
Other non-operating income (expenses) | 91.99%-1.91M | -91.28%-23.39M | -4,562.66%-14.36M | -42.68%-3.34M | 2,277.94%18.16M | -172.79%-23.85M | -127.69%-12.23M | -101.13%-308K | -126.69%-2.34M | -146.54%-834K |
Income before tax | 97.73%-63.45M | -129.51%-4.12B | -74.15%153.07M | -74.63%177.63M | -133.16%-1.66B | -136.41%-2.79B | 44.24%13.96B | -90.83%592.19M | -55.88%700.13M | 319.81%5B |
Income tax | -53.11%-270.95M | -174.33%-341.93M | -1,197.59%-214.74M | 116.49%94M | -122.01%-44.22M | -121.86%-176.96M | -79.38%460.04M | -98.40%19.57M | -176.31%-570.16M | 57.36%200.97M |
Net income | 107.94%207.51M | -127.98%-3.78B | -35.77%367.81M | -93.42%83.63M | -133.63%-1.61B | -138.13%-2.61B | 81.25%13.5B | -89.07%572.62M | 51.29%1.27B | 351.33%4.8B |
Net income continuous operations | 107.94%207.51M | -127.98%-3.78B | -35.77%367.82M | -93.42%83.63M | -133.63%-1.61B | -138.13%-2.61B | 81.25%13.5B | -89.07%572.62M | 51.29%1.27B | 351.33%4.8B |
Noncontrolling interests | 0 | 0 | 43.04%6.62B | 0 | 294.85%1.38B | 817.20%2.38B | ||||
Net income attributable to the company | 107.94%207.51M | -154.92%-3.78B | -35.77%367.81M | 176.74%83.63M | -166.75%-1.61B | -165.43%-2.61B | 144.02%6.88B | -56.67%572.62M | -122.23%-108.98M | 200.84%2.42B |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | 107.94%207.51M | -154.92%-3.78B | -35.77%367.81M | 176.74%83.63M | -166.75%-1.61B | -165.43%-2.61B | 144.02%6.88B | -56.67%572.62M | -122.23%-108.98M | 200.84%2.42B |
Gross dividend payment | ||||||||||
Basic earnings per share | 107.97%9.33 | -157.99%-169.82 | -37.94%16.47 | 189.30%3.59 | -171.25%-72.8 | -169.64%-117.08 | 148.64%292.82 | -51.93%26.54 | -119.63%-4.02 | 204.08%102.17 |
Diluted earnings per share | 107.97%9.33 | -160.99%-169.82 | -37.54%16.47 | 169.98%3.59 | -172.62%-72.8 | -174.59%-117.08 | 156.72%278.46 | -49.47%26.37 | -130.04%-5.13 | 224.96%100.25 |
Dividend per share | 0 | 100.00%40 | 100.00%40 | 0 | 0 | 0 | 0.00%20 | 0.00%20 | 0 | 0 |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |